Pfizer Says Recently Completed A Preliminary Assessment Of Certain Antiviral Compounds That Were Previously In Development And That Inhibited The Replication Of Coronaviruses; Expects To Have Results Regarding Possible Coronavirus Treatment Back By The En
Benzinga Newsdesk